We support research at the global forefront of science

Tissue engineering, regenerative &  personalized medicine, pharma, medical device industry, cosmetics, drug  discovery, and many other applications are using our technology to their advantage.

Some scientific projects using regenHU 3D bioprinters :

Scientific Publications  Partners Achievements

sss

PARTNERS ACHIEVEMENTS

Partners achievements
08.05.2019
Walliser Bote Zeitung

Die Curio Biotech SA in Visp bietet eine Alternative für Kosmetik- und Medikamententests

"Die Curio Biotech SA in Visp testet Kosmetikprodukte oder Medikamente im Labor an menschlichen Zellkulturen. Mit solchen Prozedere lassen sich viele Tierversuche vermeiden. Ein weiterer Vorteil: Es kann für Menschen gar aussagekräftigere Resultate liefern."

copyright: Walliser Bote  / Fotos WB/ANDREA SOLTERMANN

Steriler Arbeitsplatz. Dr. Chennakesava Cuddapah achtet auf eine sterile Arbeitsumgebung. Die In-vitro-Modelle und Zellkulturen dürfen nicht verunreinigt werden.

Lesen das komplet Artikel.

source : Walliser Bote Zeitung

Read more
Partners achievements
15.04.2019
Tel-Aviv University

3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts

Once again, the flexibility of our technologies is showcased. 3DDiscovery™ Evolution was adapted to FRESH 3D Bioprinting to build vascularized and perfusable cardiac patches.


ABSTRACT : "Generation of thick vascularized tissues that fully match the patient still remains an unmet challenge in cardiac tissue engineering. Here, a simple approach to 3D‐print thick, vascularized, and perfusable cardiac patches that completely match the immunological, cellular, biochemical, and anatomical properties of the patient is reported. To this end, a biopsy of an omental tissue is taken from patients....

Read more
Partners achievements
13.03.2019
AO Research Institute

A Stimuli-Responsive Nanocomposite for 3D Anisotropic Cell-Guidance and Magnetic Soft Robotics

"A novel method is presented to biofabricate anisotropic nanocomposite  hydrogels through a mild and biocompatible process driven by multiple  external stimuli: magnetic field, temperature, and light. The  functionality of this stimuliresponsive hydrogel is studied creating i)  3D cell-instructive platforms for in vitro morphogenesis, and ii) a 3D  printable magnetoresponsive ink for fabricating small-scale bioinspired soft robots"

source : Advandced Science News

Read more
Partners achievements
18.02.2019
University of Glasgow

Bioprinting with Biogelx-Ink

Álvaro Sánchez Rubio, a Ph.D. researcher at the University of Glasgow, is printing with Biogelx-Ink-S.

Source: Biogelx Limited

Read more
Partners achievements
05.02.2019
UMC Utrecht

Replicating the architecture of cartilage and bone

"This project has received funding from the European Research Council (ERC) under the: European Union’s Horizon 2020 research and innovation programme (grant agreement No [647426])"

sources: UMC Utrecht

Read more
Partners achievements
14.01.2019
IMPACT zhaw

Pionier für menschliches Gewebe aus dem Drucker

"Markus Rimann hat das Fachgebiet des Bioprinting an der ZHAW aufgebaut.  Das Ziel: menschliches Gewebe für eine effiziente Medikamentenentwicklung."

"Markus Rimann am 3D-Bioprinter, der sich hinter der Scheibe in einer  sterilen Umgebung befindet. Mit der auf dem Bildschirm geöffneten  Software, lässt sich der  Drucker steuern."

Sources
www.zhaw.ch 
IMPACT-zhaw-Dez2018


Read more
Partners achievements
05.12.2018

BioArk bridges industries with innovation

3D cell culture at Curio Biotech mimicks in vivo conditions.

Curio Biotech is a start-up CRO company providing services to clients ln the lite sciences sector of the pharma, cosmetlc, nutraceutlcal and diagnostic industries.

Curio Biotech constantly improves existing 30 cell culture systems and further develops novel in vitro models.

These novel 30 cell cultures can be used not only for in vitro drug discovery, screening of compounds and pre-clinlcal investigation, but can also be translated for various clinical applications.

ww.bilan.ch

Technology by Bilan

Read more
Partners achievements
03.09.2018
Science Daily

A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues

In our ageing society, there is a huge medical need for therapies against degenerative muscle and tendon diseases. This study by researchers from ZHAW and Novartis Institutes for  Biomedical Research describes a novel drug screening platform with  automated production of 3D musculoskeletal-tendon-like tissues,  representing a promising tool to address musculoskeletal diseases. Cells and bioink were printed using the 3DDiscovery™ bioprinter, in  dumbbell lines designed by regenHU’s integrated BioCAD™ program.

www.sciencedaily.com

Scientific publication

Read more